跳至主要内容
临床试验/NCT01098708
NCT01098708已完成不适用

Clinical Outcomes Validation in Non Ambulatory and Young Boys/Men With Duchenne Muscular Dystrophy (DMD)

Washington University School of Medicine1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2010年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Dystrophin gene mutations that predispose to early onset cardiomyopathy

研究概览

简要总结

Many therapeutic trials in DMD exclude non-ambulatory boys and men. Rate of progression in these non-ambulatory patients has been studied but consensus has not been reached for what measures are most reliable and reproducible. Furthermore, any treatment trial would be expected to demonstrate improved function and improvement in quality of life. Therefore, function, strength, and quality of life must be understood and standardized. While the goal of this proposal is to standardize clinical outcomes for therapeutic trials, careful understanding of the progression of DMD in non ambulatory boys may also lead to better medical treatment.

详细描述

For Non-ambulatory study, boys must be unable to walk without assistive devices for greater than or equal to one year.

Age at onset of study for non-ambulatory boys and men: greater than or equal to 7 years through age 22 years.

Genetic or biopsy confirmation of dystrophinopathy or clinical diagnosis of DMD with biopsy/genetic confirmation in a primary relative.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
7 Years 至 22 Years(Child, Adult)
性别
Male
接受健康志愿者

入选标准

  • For Non-ambulatory study, boys must be unable to walk without assistive devices for greater than or equal to one year.
  • Age at onset of study for non-ambulatory boys and men: greater than or equal to 7 years through age 22 years.
  • Genetic or biopsy confirmation of dystrophinopathy or clinical diagnosis of DMD with biopsy/genetic confirmation in a primary relative.

排除标准

  • For Non-ambulatory study, the inability to understand and cooperate with the testing would exclude a subject. -

结局指标

主要结局

Dystrophin gene mutations that predispose to early onset cardiomyopathy

时间窗: 3 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anne Connolly

Professor of Neurology

Washington University School of Medicine

研究点 (1)

Loading locations...

相似试验